BioTime (BTX) Posts Q3 EPS of 30c

BioTime (NYSE: BTX) reported Q3 EPS of $0.30, which may not compare with the analyst estimate of ($0.14). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.23 million.

Profitability was largely due to a fain on equity method investment in Asterias at fair value.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c